
    
      This is a prospective, non-randomized pilot study evaluating the efficacy of ReNuâ„¢ hip
      injection on patients with moderate osteoarthritis. The effects will be measured primarily
      through patient-reported outcomes questionnaires after a single injection. Patients will be
      followed up to 12 months to evaluate improvements using common pain and function subscales.
    
  